Pursuant to the Regulation 30(5) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we request you to note that the Board of Directors have authorized Chairperson ....
GAUDIUMIVF · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gaudium IVF and Women Health Ltd has informed stock exchanges that its Board of Directors has authorized three Key Managerial Personnel to determine the materiality of any event or information and to make required disclosures to the exchanges under SEBI Regulation 30. The authorized persons are Dr. Manika Khanna (Chairperson & Managing Director), Mr. Rakesh Kumar Sharma (Chief Financial Officer), and Mr. Naveen Kumar (Company Secretary & Compliance Officer). This is a routine compliance filing required under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. The disclosure is also available on the company's website. No business, financial, or operational changes have been announced.
This is a standard regulatory compliance filing with no material impact on shareholders or the stock price. It simply formalizes who within the company is responsible for assessing and disclosing material events to the stock exchanges going forward.